Literature DB >> 28640272

Zanos et al. reply.

Panos Zanos1, Ruin Moaddel2, Patrick J Morris3, Polymnia Georgiou1, Jonathan Fischell4, Greg I Elmer1,5,6, Manickavasagom Alkondon7, Peixiong Yuan8, Heather J Pribut1, Nagendra S Singh2, Katina S S Dossou2, Yuhong Fang3, Xi-Ping Huang9, Cheryl L Mayo6, Edson X Albuquerque5,7,10, Scott M Thompson1,4, Craig J Thomas3, Carlos A Zarate8, Todd D Gould1,5,11.   

Abstract

Entities:  

Year:  2017        PMID： 28640272      PMCID： PMC5638119          DOI： 10.1038/nature22085

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway.

Authors:  N T Redpath; E J Foulstone; C G Proud
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

2.  Effects of a ketamine metabolite on synaptic NMDAR function.

Authors:  Kanzo Suzuki; Elena Nosyreva; Kevin W Hunt; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2017-06-21       Impact factor: 49.962

Review 3.  Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

Authors:  D Jeffrey Newport; Linda L Carpenter; William M McDonald; James B Potash; Mauricio Tohen; Charles B Nemeroff
Journal:  Am J Psychiatry       Date:  2015-10       Impact factor: 18.112

4.  A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta.

Authors:  A Knebel; N Morrice; P Cohen
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

5.  Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.

Authors:  X Wang; W Li; M Williams; N Terada; D R Alessi; C G Proud
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

6.  Acute suppression of spontaneous neurotransmission drives synaptic potentiation.

Authors:  Elena Nosyreva; Kristen Szabla; Anita E Autry; Alexey G Ryazanov; Lisa M Monteggia; Ege T Kavalali
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

7.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

8.  Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.

Authors:  Ruin Moaddel; Galia Abdrakhmanova; Joanna Kozak; Krzysztof Jozwiak; Lawrence Toll; Lucita Jimenez; Avraham Rosenberg; Thao Tran; Yingxian Xiao; Carlos A Zarate; Irving W Wainer
Journal:  Eur J Pharmacol       Date:  2012-11-23       Impact factor: 4.432

9.  Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.

Authors:  Asli A Hizli; Yong Chi; Jherek Swanger; John H Carter; Yi Liao; Markus Welcker; Alexey G Ryazanov; Bruce E Clurman
Journal:  Mol Cell Biol       Date:  2012-11-26       Impact factor: 4.272

10.  Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.

Authors:  Bangkun Yang; Qian Ren; Min Ma; Qian-Xue Chen; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176
View more
  14 in total

Review 1.  Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Authors:  Liana Fattore; Alessandro Piva; Mary Tresa Zanda; Guido Fumagalli; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2017-11-25       Impact factor: 4.530

Review 2.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 3.  Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.

Authors:  Jaclyn N Highland; Panos Zanos; Lace M Riggs; Polymnia Georgiou; Sarah M Clark; Patrick J Morris; Ruin Moaddel; Craig J Thomas; Carlos A Zarate; Edna F R Pereira; Todd D Gould
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 4.  Convergent Mechanisms Underlying Rapid Antidepressant Action.

Authors:  Panos Zanos; Scott M Thompson; Ronald S Duman; Carlos A Zarate; Todd D Gould
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

5.  Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.

Authors:  Patrick J Morris; Ruin Moaddel; Panos Zanos; Curtis E Moore; Todd D Gould; Carlos A Zarate; Craig J Thomas
Journal:  Org Lett       Date:  2017-08-22       Impact factor: 6.005

Review 6.  Mechanisms of ketamine action as an antidepressant.

Authors:  P Zanos; T D Gould
Journal:  Mol Psychiatry       Date:  2018-03-13       Impact factor: 15.992

7.  (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.

Authors:  Lace M Riggs; Yasco Aracava; Panos Zanos; Jonathan Fischell; Edson X Albuquerque; Edna F R Pereira; Scott M Thompson; Todd D Gould
Journal:  Neuropsychopharmacology       Date:  2019-06-19       Impact factor: 7.853

8.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

9.  Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances.

Authors:  Oliver Vranjkovic; Garrett Winkler; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-05-24       Impact factor: 7.853

Review 10.  Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants.

Authors:  Todd D Gould; Carlos A Zarate; Scott M Thompson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-10-08       Impact factor: 13.820
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.